HealWELL AI is expected to report a smaller quarterly loss, but its recent earnings record is mixed. The consensus estimate also comes from just one analyst.
HealWELL AI Inc. (TSX: AIDX) is set to report results for the quarter ended September 30, 2026, after market close on November 5. The available consensus estimate is a loss of C$0.01 per share and revenue of C$34.31 million. A year earlier, the company lost C$0.05 per share. The revenue estimate implies 13.0% year-over-year growth. Over the past 30 days, the EPS estimate has improved from a loss of C$0.02 to C$0.01, based on one analyst. Follow the company on the AIDX stock page as the report approaches.
Recent earnings trend
HealWELL AI Inc.
AIDX.TO
AIDX.TO
HealWELL AI Inc.
WealthAwesomeMarket cap
$220.67M
52W high
$1.44
52W low
$0.58
1W change
-5.88%
Beta
-0.94
Analyst Price Targets
Based on analyst covering AIDX · as of Nov 3, 2026
Wall Street analysts forecast AIDX stock price to rise 673.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$1.82
+673.7% Upside
Previously C$1.84 on Sep 17, 2026
Current Price
C$0.23
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AIDX's historical volatility
30-Day Vol
48.8%
Annualized
90-Day Vol
47.4%
Annualized
Trend (90d)
-6.3%
Annualized drift
90d Mean
C$0.65
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.66 | C$0.55 – C$0.78 |
| 60 trading days | C$0.65 | C$0.51 – C$0.82 |
| 90 trading days | C$0.65 | C$0.48 – C$0.86 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 1 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 1 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-09-30 | 2026-11-09 | — | -0.0200 | — |
| 2026-06-30 | 2026-08-06 | -0.0300 | -0.0200 | -50.0% |
| 2026-03-31 | 2026-05-07 | -0.0200 | -0.0200 | +0.0% |
| 2025-12-31 | 2026-03-19 | -0.0109 | -0.0200 | +45.5% |
| 2025-09-30 | 2025-11-06 | -0.0500 | -0.0200 | -150.0% |
| 2025-06-30 | 2025-08-13 | -0.0300 | -0.0100 | -200.0% |
Investor takeaway: The report will show whether HealWELL can grow revenue while narrowing its losses. The EPS estimate points to year-over-year improvement, but the company is still expected to lose money, and the one-analyst consensus is limited. HealWELL beat estimates in one of its last four comparable quarters: it missed in June 2026, matched in March, beat in December 2025, and missed in September 2025. That record makes the underlying results and outlook more useful than whether the company simply beats estimates.
C$34.31 million
That’s the consensus revenue estimate for the September quarter, representing expected growth of 13.0% from a year earlier. The EPS estimate is a loss of C$0.01 per share and comes from one analyst. Revenue results and management’s comments on the path to profitability will help put the expected loss in context.
Bull case
The C$34.31 million revenue estimate points to 13.0% year-over-year growth. The expected loss of C$0.01 per share is also smaller than the C$0.05 loss a year earlier, and the estimate has improved over the past month. Recent company announcements describe a Canadian rollout of its SMART Summary tool across New Brunswick. More than 400 clinicians can access it through Intrahealth’s Profile EMR. The results may show whether these deployments and HealWELL’s health-care AI work are contributing to revenue and helping reduce losses.
Bear case
HealWELL is still losing money. Its trailing 12-month EPS is -C$0.09, and its reported profit margin is -23.01%. In the latest reported quarter, ended June 30, 2026, the company lost C$0.03 per share, compared with an estimated loss of C$0.02. Over the past four quarters, it missed estimates twice, matched once and beat once. Since one analyst provides the upcoming EPS estimate, even a small difference from -C$0.01 could look like a large percentage surprise without changing the longer-term picture. The available information also doesn’t include a revenue history or a margin forecast for this quarter.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
